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Background: Early detection of oral cancer is the most effective means of reducing morbidity, complexity, and 
extent of treatment. This study evaluated the clinicopathological profile of epidermoid carcinoma of the tongue, 
including treatment and survival. 
Material and Methods: This observational, retrospective cross-sectional study evaluated patients with squamous 
cell carcinoma of the tongue treated at the Dr. Luiz Antônio Hospital, Natal, Brazil, from January 2001 to De-
cember 2011. Survival variables were calculated using the Kaplan-Meier method and compared by log rank tests.
Results: Of the 412 patients diagnosed in this period, 298 (72.3%) were men; their mean age was 60.5 years, and 
69.2% were diagnosed with stage III/IV tumours. Improved survival was associated with early stage diagnosis, 
absence of affected lymph nodes at diagnosis, and treatment with surgery alone. 
Conclusions: Late stage diagnosis of oral cancer negatively affects patient survival. In addition, the general pub-
lic should be made aware of the prognostic factors for oral SCC of the tongue and of the importance of periodic 
examinations of the oral cavity.
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Introduction
Cancer is a major cause of morbidity and mortality world-
wide, with incidence rates varying widely depending on 
geographic location, age, sex and race (1). Low and mid-
dle income countries have proportionately higher cancer 
burdens than high income countries, but their health sys-
tems are unprepared to address this problem (2).
Oral squamous cell carcinoma (SCC) is the most com-
mon type of cancer affecting the oral mucosal epithe-
lium (3). Its worldwide incidence is quite variable, being 
the main type of cancer in Southeast Asian countries. 
Cancer of the oral cavity is classified as a type of head 
and neck tumour. For Brazil, an estimated 11,200 new 
cases of oral cavity cancer in men and 3,500 in women 
are estimated for each year of the 2018-2019 biennium. 
These figures correspond to an estimated risk of 10.86 
new cases per 100,000 men, ranking fifth; and 3.28 for 
every 100,000 women, being the 12th most frequent 
among all cancers (4).
The main risk factors for the development of SCC are 
the consumption of tabaco and alcohol and HPV infec-
tions, but only a fraction of these exposed people deve-
lop this neoplasia (5). These findings suggest that theory 
that genetic factors are individuals that contribute to 
greater susceptibility, differences in clinical behaviour 
and patient prognosis (5,6).
Although oral SCC can develop in various areas of the 
oral cavity, its highest incidence is in the tongue. Post-
surgical recurrence rates are high, as is the propensity 
to develop regional lymph node metastases. Among pa-
tients with oral tumours, those with SCC of the tongue 
have the poorest survival rates (7,8). 
Tumour aggressiveness has been associated with seve-
ral factors, including the histological grade of malig-
nancy, lesion size, the presence of metastases present at 
diagnosis and the anatomical location of the tumour (9). 
Treatment of these tumours, which can include surgery, 
radiotherapy and/or chemotherapy, depends largely on 
tumour location, clinical stage, histopathologic grad-
ing and the physical condition of the patient. The 5-year 
survival rate is about 50%, with no major changes in the 
past three decades, despite advances in treatment (10).
Efforts are needed to evaluate the clinical and patho-
logical parameters and diagnostic methods that can 
expedite the early detection of oral cancer and thus im-
prove patient prognosis. This study therefore evaluated 
the clinicopathological characteristics of patients diag-
nosed with SCC of the tongue and treated at a single 
centre over an 11-year period, as well as evaluating the 
survival of these patients.
Material and Methods
This retrospective, sectional study included patients 
histopathologically diagnosed with SCC of the tongue 
who were treated at Dr. Luiz Antonio Hospital, Na-
tal, Brazil, between January 2001 and December 2011. 
Patients were excluded if they had oral SCC at other 
sites or if their medical records did not report metas-
tasis, recurrence and survival or if they only under-
went incisional biopsy. Data collected from patients’ 
medical records included sex; age; presence of lymph 
node metastasis, distant metastasis, or local recurrence; 
treatment; overall survival; and last record date or date 
of death. The study protocol was approved by the Re-
search Ethics Committee of the Northern League Hu-
man Riograndense Against Cancer (CEP / LIGA (Ap-
proval No. 923192/2014), which waived the requirement 
for informed consent due to the retrospective nature of 
this study.
All data were analysed statistically using Stata / IC ver-
sion 12.0 software (Stata Corp, College Station, TX). 
Survival variables were calculated using the Kaplan-
Meier method and compared by log rank tests. Multi-
variate analysis of factors associated with survival was 
performed using the Cox stepwise regression model (hi-
erarchical), from the highest to the lowest hazard ratio 
(HR). Variables selected to enter the model were those 
having a p-value ≤ 0.250 on log rank tests, a p-value 
> 0.05 on proportionalities tests, with risk proportion-
alities graphs not touching. Models with a p-value ≤ 
0.05 were considered statistically significant. Analysis 
of model waste by Sehoenfeld, Cox-Snell and residual 
score (DFBETA) tests showed that no individual patient 
result could interfere. Significant associations between 
clinicopathologic features and outcomes were evaluated 
using chi-square tests, with a p-value ≤ 0.05 considered 
statistically significant.
Results
Of the 412 patients included in the study, 298 (72.3%) 
were men and 114 (27.7%) were women. Their mean age 
was 60.5 ± 14.1 years (range, 19–100 years). Evaluation 
of educational level showed that 117 (28.4%) patients 
were illiterate and 189 (45.9%) had some schooling (pri-
mary, secondary or higher); information on the remain-
ing 106 (25.7%) patients was not found in their medical 
records (Table 1, 1 continue).
Seventeen (4.12%) patients had more than one primary 
tumour, confirming that these tumours may be pre-
sent at more than one anatomical site. In addition, 76 
(18.45%) patients were diagnosed early, contributing to 
best survival.
Tobacco use and alcohol consumption were reported by 
313 (76%) and 241 (58.5%) patients, respectively. Only 
23 (5.6%) patients reported that they were never smokers 
and 76 (18.4%) stated that they did not consume alcohol. 
The male sex most associated with smoking (p = 0.005, 
1.79 times more than women) and alcohol (p <0.0001, 
4.80 times more than women).
Analysis by type of treatment showed that 35 (8.5%) pa-
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n % % Valid % Accumulated
T
T1 10 2,4 3,2 3,2
T2 72 17,5 23,4 26,6
T3 87 21,1 28,2 54,9
T4 136 33,0 44,2 99,0
TX 3 ,7 1,0 100,0
Total 308 74,8 100,0
                             No information 104 25,2
N
N0 125 30,3 40,6 40,6
N1 63 15,3 20,5 61,0
N2 75 18,2 24,4 85,4
N3 35 8,5 11,4 96,8
NX 10 2,4 3,2 100,0
Total 308 74,8 100,0
                              No information 104 25,2
M
M0 219 53,2 71,1 71,1
M1 8 1,9 2,6 73,7
MX 81 19,7 26,3 100,0
Total 308 74,8 100,0
                              No information 104 25,2
TNM
I 14 3,4 4,0 4,0
II 54 13,1 15,3 19,3
III 87 21,1 24,6 43,9
IVA 157 38,1 44,5 88,4
IVB 33 8,0 9,3 97,7
IVC 8 1,9 2,3 100,0
Total 353 85,7 100,0
                            No information 59 14,3
SEX
Male 298 72,3 72,3 72,3
Female 114 27,7 27,7 100,0
IGE
0 - 60 212 51,5 51,5 51,5
> 60 200 48,5 48,5 100,0
Table 1. Clinical and demographic data.
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tients did not undergo any kind of treatment (denial of 
the patient and terminal stages), 122 (29.6%) underwent 
chemotherapy and radiation therapy, and 131 (31.8%) 
underwent surgery and associated treatment. Of 123 
patients, 74 (18.2%) underwent surgery alone, 34 (8.3%) 
received radiotherapy alone and 15 (3.6%) received che-
motherapy alone.
Evaluation of TNM classification showed that 223 
(54.1%) patients presented with local extension, includ-
ing 87 (21.1%) classified as T3 and 136 (33%), as T4. 
Only 10 (2.4%) patients were classified as T1, indicat-
n % % Valid % Accumulated
SCHOOLING
Illiterate 117 28,4 38,2 38,2
Elementary School
incomplete 119 28,9 38,9 77,1
Elementary School
complete 32 7,8 10,5 87,6
High school 29 7,0 9,5 97,1
Higher education 9 2,2 2,9 100,0
Total 306 74,3 100,0
                           No information 106 25,7
DRINKING
Never 76 18,4 23,0 23,0
Do not drink more 14 3,4 4,2 27,2
Yes 241 58,5 72,8 100,0
Total 331 80,3 100,0
                              No information 81 19,7
SMOKER
Never 23 5,6 6,4 6,4
Ex-Smoker 24 5,8 6,7 13,1
Yes 313 76,0 86,9 100,0
Total 360 87,4 100,0
                             No information 52 12,6
TREATMENT
No 35 8,5 8,5 8,5
Surgery 74 18,2 18,2 26,7
Radiotherapy 34 8,3 8,3 35,0
Chemotherapy 15 3,6 3,6 38,6
Surgery and radiotherapy 44 10,7 10,7 49,3
Chemo and radiation therapy 122 29,6 29,6 78,9
Surgery, chemo and radiotherapy 87 21,1 21,1 100,0
Table 1 cont. Clinical and demographic data.
ing that few patients are diagnosed at an early stage of 
the disease. Information on T stage was not available 
for 59 (14.3%) patients. Assessment of regional spread 
(N), showed that 125 (30.3%) patients were classified as 
N0 and 110 (26.7%) as N2 and N3, with information not 
available for 104 (25.2%) patients. Evaluation of TNM 
classification showed that 68 (16.5%) were stage I or II 
and 285 (69.2%) were stage III or IV.
Of the 412 patients, 86 (20.8%) were censored and 224 
(54.36%) died within five years. Median overall sur-
vival (OS) was 1.77 years (95% confidence interval [CI] 
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Fig. 1. Survival function Kaplan-Meier.
1.42–2.53 years). The 5-year OS rate was 42.61% (95% 
CI 37.56–47.56%) and remained stable thereafter (Fig. 1).
The mean time of patients who died was 24.6 months. 
Twenty (8.92%) patients were monitored for ≤ 0.1 month, 
with the remainder followed-up for 0.1–96 months.
Univariate analysis showed that factors associated with 
OS included T and N stage (TNM) and treatment (yes/
no) (Table 2). Multivariate analysis using a Cox regres-
sion model showed that for only T stage (TNM) and 
treatment (yes/no) were independent predictors of OS. 
Poorest survival outcomes were observed in patients 
with T3 and T4 tumours who did not undergo treatment 
(Table 3).
Evaluation of the association between clinicopathologi-
cal features and patient outcomes showed that smoking, 
treatment (yes/no), surgical treatment, chemotherapy 
and staging were significantly associated with survival 
(p <0.05 each).
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Female 55 49,46 1
Male 169 39,83 1,274 1,121-1,468 0,047
Age
> 60  years 103 45,62 1
0-60  years 121 39,89 1,099 0,832-1,090 0,485
T
T1 and T2 28 64,92 1
T3 and T4 160 25,61 3,058 2,044-4,574 <0,001
N
N- 59 50,52 1
N+ 124 26,12 2,096 1,535-2,861 <0,001
M
M- 120 43,24 1
M+ 7 12,50 2,024 0,943-4,343 0,064
Staging
I and II 17 74,36 1
III and IV 186 31,65 3,743 2,274-6,155 <0,001
Habit
Drink
No 47 46,60 1
Yes 151 33,94 1,305 0,940-1,810 0,109
Habit
Smoke
No 19 58,54 1
Yes 186 38,11 1,592 0,992-2,553 0,049
Treatment
Yes 192 46,09 1
No 32 4,35 7,712 5,211-11,411 <0,001
Surgery
Yes 70 62,49 1
No 154 23,55 1,711 1,612-1,882 <0,001
Radiotherapy
No 56 53,81 1
Yes 168 38,90 1,030 0,761-1,395 0,845
Chemotherapy
No 84 52,55 1
Yes 140 35,36 1,230 0,938-1,613 0,133
Table 2. Univariate and proportionality assessment.
HR: Hazard Ratio; CI 95%: Confidence Interval of 95%.
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7,712 10,775 8,102-20,654 <0,001
TNM
T1 and T2 1 1
T3 and T4










1,592 1,034 0,685-1,561 0,872
Sex
Female 1 1
Male 1,274 1,061 0,729-1,542 0,756
Table 3. Multivariate analysis with adjusted Cox regression.
HR: Hazard Ratio; CI 95%: Confidence Interval of 95%.
Discussion
The incidence and mortality rates from oral cancer are 
high in various populations. Moreover, oral cancer can 
have a negative effect on patient quality of life, caus-
ing problems in swallowing and speaking, as well as 
significant facial disfigurements that can lead to serious 
problems in patients’ social lives (2).
SCC of the tongue is the most common cancer of the oral 
cavity, accounting for 25% to 40% of affected patients. 
The tongue has a rich lymphatic network and muscle 
structure, making the tongue the site most often associ-
ated with cervical metastases from tumours at other sites 
in the mouth, resulting in poor patient prognosis (12).
The main risk factors associated with oral SCC of the 
tongue are genetic predisposition, immune system sup-
pression, nutritional deficiencies, and exposure to the 
carcinogenic effects of smoking and alcohol consump-
tion (6). These factors can have a synergistic effect, with 
the incidence of oral SCC of the tongue being directly 
proportional to the amount and duration of exposure. 
Other factors as solar radiation exposure and viruses 
infections, including human papilloma virus (HPV) 
which are more specific of other SCC, respectively the 
lip and oropharynx (1,5,11). The majority of studies of 
oral SCC found that all reported alcohol consumption 
and/or smoking tobacco (10-18).
Treatment of oral SCC of the tongue usually includes 
surgery and/or radiation therapy and/or chemotherapy. 
Few malignancies at present are treated with only one 
modality. Multidisciplinary care, integrating cancer 
services (surgery, radiotherapy and chemotherapy) with 
each other and general services is therefore important 
(4).
Surgery and radiation therapy have shown favourable 
results in the treatment of early lesions, with outcomes 
depending on tumour location and functional changes 
caused by treatment. Although the cure of early lesions 
is about 80%, about 10–20% of early lesions, especially 
those located on the tongue and/or mouth floor, may 
have subclinical spread to the cervical lymph nodes. 
These patients may require a combination of surgery 
and radiotherapy (4). Patients with more advanced tu-
mours, who are not candidates for surgery, are frequent-
ly treated with combinations of chemotherapy and ra-
diotherapy. These patients generally have an extremely 
poor prognosis, because of the inability to fully control 
these more extensive lesions (4). Observed facto in the 
service evaluated in this study.
To determine the most effective clinical approach, it is 
necessary to evaluate factors significantly prognostic of 
survival. Factors found to have a significant negative ef-
fect on patient survival include age >60 years, lesion in 
the tongue, thickness of the primary tumour between 
T3 and T4 and clinical TNM stage III or IV (13-17). 
Tongue SCC occurs primarily in men aged ≥60 years 
(10,14-17). Similarly, our study of 412 patients with 
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tongue SCC treated at the Hospital Dr. Luiz Antônio, 
Natal, Brazil, found that 72.3% of patients with tongue 
SCC were male, probably because are more exposed to 
risk factors, including alcohol and tobacco consump-
tion, both of which are more common habits in men 
than in women (p<0,05).
Similar to previous findings (14-17), the patients in our 
study were of mean age 60.5 ± 14.1 years (range, 19–100 
years), with 51.0% aged 0–60 years (50.96%). The high-
est prevalence by decade was in patients aged 50–59 
years (26.21%), in agreement with earlier results (8).
Patient prognosis is improved if oral SCC of the tongue 
is identified at an early stage. At this stage, however, 
patients have few or no symptoms, with this absence 
contributing to delayed diagnosis and treatment (10). 
For this reason the clinical signs are important for the 
early diagnosis, so any alteration in the oral cavity that 
persists for 15 days or more, seek a dental surgeon for 
evaluation. The self-examination done by the patient 
may also help in this early diagnosis (3,4).
Treatment is dependent the tumour site, disease stage 
and general patient health. An earlier diagnosis will re-
quire less aggressive treatment, resulting in better func-
tion and aesthetic outcomes (8,9). One study reported 
better overall survival in patients undergoing surgery 
alone than other forms of therapy (10). In contrast, the 
5-year overall survival rate in patients treated with dif-
ferent therapeutic modalities was reaching 24% (10). 
According to the Almeida (13) classification, the main 
factors influencing patient prognosis and survival in-
clude the size and location of the primary tumour, re-
gional lymph node involvement, and the presence of 
distant metastases, with all of these factors included 
in TNM stage. Prognosis is significantly better in pa-
tients with stage I than stage IV tumors (10,18). This 
study found that tumour size (T stage) and the presence 
of lymph nodes at diagnosis (N stage) were significant 
predictors of patient outcomes. This finding indicates 
that T and N stages can be considered independent fac-
tors prognostic of overall survival in this group of pa-
tients and that patients without lymph node metastases 
at initial diagnosis and with T1 or T2 tumours have a 
higher survival rate (64.92%), confirming previous re-
sults (10,18).
After analysing the high mortality rates evidenced in 
this study and the published reports, it can be concluded 
that this is a serious disease because of the difficulties 
of access to adequate treatment, medical professionals 
often not able to make the appropriate initial diagnosis, 
and neglect of patients not seeking care but having ha-
bits that trigger the disease, corroborating with several 
surveys (10-18).
Therefore, it is not enough to treat the cancer, but it 
is also necessary to improve access to health care for 
the population and raise awareness about the risk fac-
tors associated with this disease and related illnesses 
and train professionals to undertake the diagnosis right. 
Early detection is the best way to ensure the survival of 
a cancer patient. It can represent efficacy in the treat-
ment until the patient cures, being one of the main find-
ings of this research.
This study evaluated the clinical and pathological pa-
rameters associated with improved survival in patients 
with oral SCC of the tongue. The absence of lymph node 
metastases at diagnosis and smaller tumour size were 
predictive of better survival. Campaigns and projects 
to encourage and promote the early diagnosis of cancer 
among health professionals are necessary. In addition, 
the general public should be aware of the risk factors and 
prognostic factors for oral SCC of the tongue and of the 
importance of periodic examinations of the oral cavity.
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